Next >>

Knapen, D., M. Angrish, M. Fortin, I. Katsiadaki, M. Leonard, L. Mariotta-Casaluci, S. Munn, J. O'Brien, N. Pollesch, L. Smith, X. Zhang, AND Dan Villeneuve. Adverse outcome pathway networks I: Development and applications. ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY. Society of Environmental Toxicology and Chemistry, Pensacola, FL, 37(6):1723-1733, (2018).

Villeneuve, Dan, M. Angrish, M. Fortin, I. Katsiadaki, M. Leonard, L. Margiotta-Casaluci, S. Munn, J. O'Brien, N. Pollesch, C. Smith, X. Zhang, AND D. Knapen. Adverse outcome pathway networks II: Network analytics. ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY. Society of Environmental Toxicology and Chemistry, Pensacola, FL, 37(6):1734-1748, (2018).

Knapen, D., M. Angrish, M. Fortin, I. Katsiadaki, M. Leonard, L. Margiotta-Casaluci, S. Munn, J. O'Brien, N. Pollesch, L. Smith, X. Zhang, AND Dan Villeneuve. Adverse outcome pathway networks: Development, analytics and applications. SETAC Europe, Rome, ITALY, May 13 - 17, 2018.

Mortensen, H., J. Chamberlin, B. Joubert, M. Angrish, N. Sipes, JaniceS Lee, AND S. Euling. Leveraging human genetic and adverse outcome pathway (AOP) data to inform susceptibility in human health risk assessment. Mammalian Genome. Springer, New York, NY, 29(1):190-204, (2018).

Winters, B., M. Angrish, A. Wallace, J. Pleil, AND M. Madden. Metabolomics Approach for Toxicity Screening of Volatile Substances. Society of Toxicology, San Antonio, TX, March 11 - 15, 2018.

Knapen, D., M. Angrish, M. Fortin, I. Katsiadaki, M. Leonard, L. Margiotta-Casaluci, S. Munn, J. O'Brien, N. Pollesch, C. Smith, X. Zhang, AND Dan Villeneuve. Adverse outcome pathway networks: Development, analytics, and applications. SETAC North America, Minneapolis, MN, November 12 - 16, 2017.

Oki, N., S. Bell, M. Angrish, C. Grant, R. Wang, AND S. Edwards. Computationally predicted Adverse Outcome Pathway networks for liver-related diseases using publicly available data sources: Case studies and lessons learned. SOT Annual Meeting, Baltimore, MD, March 12 - 16, 2017.

Winters, B., M. Angrish, A. Wallace, AND M. Madden. In Vitro Toxicity Assessment Technique for Volatile Substances using Cytochrome P450 Isozyme-specific metabolic pathways. PittCon, Chicago, IL, March 05 - 09, 2017.

Winters, B., M. Angrish, A. Wallace, J. Pleil, AND M. Madden. In Vitro Toxicity Screening Technique for Volatile Substances Using Flow-Through System. Carolinas Soc Env Toxicol & Chem, Charleston, SC, May 14, 2001 - May 17, 2017.

Winters, B., M. Angrish, A. Wallace, J. Pleil, AND M. Madden. In Vitro Toxicity Screening Technique for Volatile Substances Using Flow-Through System#. Society of Toxicology Annual Meeting, Baltimore, MD, March 12 - 16, 2017.

Winters, B., M. Angrish, A. Wallace, J. Pleil, AND M. Madden. In Vitro Toxicity Screening Technique for Volatile Substances Using Flow-Through System##. Gordon Research Conference-Advanced Investigation in Mechanistic Toxicology, Andover, NH, August 13 - 18, 2017.

Winters, B., M. Angrish, A. Wallace, M. Madden, AND J. Pleil. In Vitro Toxicity Screening Technique for Volatile Substances Using Flow-Through System@@. NC SOT, RTP, NC, October 30, 2017.

Angrish, M., C. McQueen, E. Hubal, M. Bruno, Y. Ge, AND B. Chorley. Mechanistic Toxicity Tests Based on an Adverse Outcome Pathway Network for Hepatic Steatosis. TOXICOLOGICAL SCIENCES. Society of Toxicology, RESTON, VA, 159(1):159-169, (2017). https://doi.org/10.1093/toxsci/kfx121

Angrish, M., J. Rooney, C. McQueen, AND B. Chorley. Project Number: CSS 12.01 Adverse Outcome Pathway Discovery and Development (AOP-DD)Task Number: Task 1.1d: Putative AOP development related to Fatty Liver Disease (steatosis) Product number: Key Product 1 (AOP knowledgebase development). Society of Toxicology Annual Meeting, Baltimore, MA, March 12 - 16, 2017.

Chorley, B., G. Nelson, M. Angrish, M. Cave, M. Pavuk, C. Pinkston, AND G. Carswell. Serum microRNA biomarker identification in a residential cohort with elevated polychlorinated biphenyl exposures. SOT 56th Annual Meeting, Baltimore, MD, March 12 - 16, 2017.

Winters, B., J. Pleil, M. Angrish, M. Stiegel, T. Risby, AND M. Madden. Standardization of the collection of exhaled breath condensate and exhaled breath aerosol using a feedback regulated sampling device. Journal of Breath Research. Institute of Physics Publishing, Bristol, Uk, 11(4):1, (2017). https://doi.org/10.1088/1752-7163/aa8bbc

Nelms, M., C. Mellor, M. Angrish, B. Chorley, S. Enoch, J. Madden, J. Simmons, M. Cronin, AND S. Edwards. Use of an Adverse Outcome Pathway for Hepatic Steatosis to Build Chemical Groups. OpenTox USA 2017, Durham, NC, July 12 - 13, 2017.

Nelms, M., C. Mellor, M. Angrish, B. Chorley, S. Enoch, J. Madden, J. Simmons, M. Cronin, AND S. Edwards. Using Adverse Outcome Pathways to Build Chemical Groups: A Case Study for Hepatic Steatosis. SOT Annual Meeting, Baltimore, MD, March 12 - 16, 2017.

Angrish, M., Jonathan-Phillip Kaiser, C. McQueen, AND B. Chorley. Adverse Outcome Pathway (AOP) Network Development for Fatty Liver. Society of Toxicology 55th Annual Meeting and ToxExpo, New Orleans, LA, March 13 - 16, 2016.

Angrish, M., P. Cagle, S. Padilla, A. Tennant, J. Hedge, B. Chorley, AND T. Tal. An Embryonic Zebrafish Screening Method for Early Life-stage Obesity. NC SOT Annual Meeting, Research Triangle Par, NC, October 25, 2016.

Angrish, M. AND B. Chorley. Epigenomic Applications in an Adverse Outcome Pathway for Obesity. Toxicoepigenetics, Tysons, VA, November 02 - 04, 2016.

Angrish, M., S. Padilla, B. Chorley, AND A. Tennant. Fetal Origins of Life Stage Disease: A Zebrafish Model for the Obesity Epidemic. EMGS Annual Meeting 2016, Kansas City, MO, September 24 - 28, 2016.

Winters, B., M. Angrish, S. Mentese, M. Madden, AND J. Pleil. Gas-Phase Molecular Probe For High Throughput Screening. Gordon Conference Drug Safety, Easton, MA, June 25 - July 01, 2016.

Winters, B., M. Angrish, A. Wallace, J. Pleil, AND M. Madden. In Vitro Toxicity Assessment Technique for Volatile Substances Using Flow-Through System. NC Society of Toxicology, RTP, NC, October 25, 2016.

Bell, S., M. Angrish, C. Wood, AND S. Edwards. Integrating publicly-available data to generate computationally-predicted adverse outcome pathways for hepatic steatosis. TOXICOLOGICAL SCIENCES. Society of Toxicology, RESTON, VA, 150(2):510-520, (2016).